Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e244c45db64b3125b045c0f703bba7f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdcd15fe3ba689551a67bfe34e7a1ca2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92dea485ccfcad1c286c61fdfce2e5d1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6901 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0221 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
filingDate |
2008-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef7717ddc10fca361f4a2c11a28c9a34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e8d1cd366152f68ef79b84d7149ff7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfbbc82ac4c8740628488816932f2124 |
publicationDate |
2009-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009041737-A1 |
titleOfInvention |
Cold storage of modified platelets |
abstract |
A method for storing and using platelets and an associated platelet structure. At least one modified platelet is formed. Each modified platelet includes a platelet and at least one polymerated chemical. Each polymerated chemical includes a polymer covalently bonded directly to the platelet or includes the polymer and a linker molecule such that the linker molecule is covalently bonded to the platelet and the polymer is covalently attached to the linker molecule. The polymer of each polymerated chemical of each modified platelet is polyethylene glycol (PEG) or a PEG derivative. Forming each modified platelet does not include modifying the platelet membrane of each platelet with a glycan-modifying agent. The at least one modified platelet is stored in a temperature range below 0° C. After being stored, the at least one modified platelet may be introduced into a subject to treat a condition related to a reduced platelet function. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102009059274-B4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11172673-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016164693-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10897891-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021146343-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102009059274-A1 |
priorityDate |
2007-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |